SCHEMBL7793447

SCHEMBL7793447

O=C(/C=C/c1ccccc1)NC(CSSCC(NC(=O)/C=C/c1ccccc1)C(=O)NCCc1ccccc1)C(=O)NCCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 5/20 0.64
MMP2 P08253 5/20 0.64
MMP9 P14780 5/20 0.64
POLB P06746 1/20 0.64
RECQL P46063 1/20 0.64
PLAAT3 P53816 2/20 0.54
PLAAT5 Q96KN8 2/20 0.54
PLAAT2 Q9NWW9 2/20 0.54
PLAAT4 Q9UL19 2/20 0.54
ALDH1A1 P00352 4/20 0.54
MAPT P10636 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
MAPK1 P28482 1/20 0.54
CYP2C19 P33261 1/20 0.54
NLRP3 Q96P20 1/20 0.54
HDAC3 O15379 1/20 0.53
HDAC4 P56524 1/20 0.53
HDAC1 Q13547 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793454 1.00 MMP1 (0.64) MMP1MMP2MMP9POLBRECQL
SCHEMBL7793458 0.81 MMP1 (0.49) MMP1MMP2MMP9POLBRECQL
SCHEMBL7793435 0.80 CA12 (0.52) POLBALDH1A1CYP2C9CYP2C19HPGD
SCHEMBL6233942 0.79 MMP1 (1.00) MMP1MMP2MMP9POLBRECQL
SCHEMBL28891887 0.79 MMP1 (1.00) MMP1MMP2MMP9POLBRECQL
SCHEMBL16473431 0.79 MMP1 (1.00) MMP1MMP2MMP9POLBRECQL
SCHEMBL7793390 0.79 KMT2A (0.57) ALDH1A1HDAC2HDAC8HDAC6HPGD
SCHEMBL7799262 0.78 POLB (0.52) POLBCYP2C9CYP2C19KMT2A
SCHEMBL7798914 0.77 POLB (0.48) MMP1MMP2MMP9POLBRECQL
SCHEMBL7798889 0.74 NPC1 (0.64) POLBPLAAT3PLAAT5PLAAT2PLAAT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed